<SEC-DOCUMENT>0001493152-21-032474.txt : 20211227
<SEC-HEADER>0001493152-21-032474.hdr.sgml : 20211227
<ACCEPTANCE-DATETIME>20211227070512
ACCESSION NUMBER:		0001493152-21-032474
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20211222
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211227
DATE AS OF CHANGE:		20211227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Microbot Medical Inc.
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		211518904

	BUSINESS ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043
		BUSINESS PHONE:		908-938-5561

	MAIL ADDRESS:	
		STREET 1:		25 RECREATION PARK DR SUITE 108
		CITY:			HINGHAM
		STATE:			MA
		ZIP:			02043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STEMCELLS INC
		DATE OF NAME CHANGE:	20000524

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:MBOT="http://microbotmedical.com/20211222">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_MBOT_microbotmedical.com_20211222 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20211222_20211222 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000883975 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityCentralIndexKey">0000883975</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mbot-20211222.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-12-22to2021-12-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000883975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-22</xbrli:startDate>
        <xbrli:endDate>2021-12-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 12pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_90C_edei--DocumentType_c20211222__20211222_zGh6zSrXplf2"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Pursuant
to Section 13 or 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>of
the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Date
of Report (Date of earliest event reported): <span id="xdx_90F_edei--DocumentPeriodEndDate_c20211222__20211222_zVGg8gFHbMCd"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 22, 2021</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 18pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--EntityRegistrantName_c20211222__20211222_zvyEc5Is7b85"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityRegistrantName">MICROBOT
MEDICAL INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20211222__20211222_zzUIuae8HVj1"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityFileNumber_c20211222__20211222_zR6xipNX1vgc"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityFileNumber">000-19871</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20211222__20211222_z0p4EXXzE5ta"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityTaxIdentificationNumber">94-3078125</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20211222__20211222_zxOOtTJzEN7"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityAddressAddressLine1">25
Recreation Park Drive</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20211222__20211222_zaLfxpoRFkCl"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityAddressAddressLine2">Unit 108</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20211222__20211222_z7L8nPfH2ONd"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityAddressCityOrTown">Hingham</ix:nonNumeric></span>,
<span id="xdx_903_edei--EntityAddressStateOrProvince_c20211222__20211222_z7Rw11RbzKR8"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20211222__20211222_zOotRevFk1mg"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:EntityAddressPostalZipCode">02043</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Address
of Principal Executive Offices) (Zip Code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Registrant&#8217;s
telephone number, including area code: <span id="xdx_909_edei--CityAreaCode_c20211222__20211222_zvgAKpELhvHl"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:CityAreaCode">(781)</ix:nonNumeric></span> <span id="xdx_904_edei--LocalPhoneNumber_c20211222__20211222_zdUxs3QnNkk5"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:LocalPhoneNumber">875-3605</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Former
Name or Former Address, if Changed Since Last Report)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_904_edei--WrittenCommunications_c20211222__20211222_zBmLoh2nZ421"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span><span style="font: 10pt Times New Roman, Times, Serif"></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"></span><span id="xdx_90F_edei--SolicitingMaterial_c20211222__20211222_znBH8qYatMPb"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"></span><span id="xdx_90C_edei--PreCommencementTenderOffer_c20211222__20211222_zhbbveXtB1Ll"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"></span><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20211222__20211222_zLi2ty1D0SE9"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--Security12bTitle_c20211222__20211222_zeZmouZRhSKg"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--TradingSymbol_c20211222__20211222_zzdJu52kIf6k"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" name="dei:TradingSymbol">MBOT</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span><span id="xdx_905_edei--SecurityExchangeName_c20211222__20211222_z5nlWTMp7sq8"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
Growth Company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20211222__20211222_zQwK0VQJMvXg"><ix:nonNumeric contextRef="From2021-12-22to2021-12-22" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Entry
    into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2021, Microbot Medical Inc. (the &#8220;Company&#8221;) entered into a strategic collaboration agreement for technology
co-development (the &#8220;Agreement&#8221;) with Stryker Corporation, acting through its Neurovascular Division (&#8220;Stryker&#8221;).
Pursuant to the Agreement, the collaborative development program between the Company and Stryker aims to integrate certain of
Stryker&#8217;s instruments with the Company&#8217;s LIBERTY Robotic System to address certain neurovascular procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
activities contemplated by the Agreement shall be specified in one or more development plans derived from the terms and conditions set
forth in the Agreement. Each party bears its own costs and expenses in connection with the performance of the Agreement and its assigned
development activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Each
of the Company and Stryker shall retain its right, title and interest to its existing intellectual property. Jointly developed intellectual
property shall be owned by a party, based on the nature of the intellectual property as it relates to each parties&#8217; respective
business, and licensed back to the other party pursuant to a worldwide, irrevocable, perpetual, royalty-free, paid-up, nonexclusive,
sub-licensable license. Jointly developed intellectual property that is not exclusively pertaining to one party&#8217;s business shall
be jointly and equally owned by both the Company and Stryker.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
term of the Agreement continues until the completion of the last development plan agreed upon, unless earlier terminated pursuant to
the terms of the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Each
of the Company and Stryker are subject to customary terms regarding non-disclosure of the other&#8217;s confidential information, and
are further subject to mutual indemnification obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
foregoing description of the terms of the Agreement is not complete and is qualified in its entirety by reference to the text of the
Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    7.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Regulation
    FD Disclosure.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">On
December 27, 2021, the Company issued a press release announcing the entering into of the Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">The
press release furnished as Exhibit 99.1 to this Current Report on Form 8-K is incorporated herein by reference. The information in this
Item 7.01 (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be &#8220;filed&#8221; for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This
report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
    9.01.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
    Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>(d)
Exhibits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.7in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Exhibit<br />
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex10-1.htm">Technology Co-Development Agreement with Stryker Corporation, acting through its Neurovascular Division (1)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif"><a href="ex99-1.htm">Press release</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify; padding-left: 10pt; text-indent: -10pt; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
  <td style="text-align: justify; padding-left: 0pt; text-indent: 0pt"><span style="font: 10pt Times New Roman, Times, Serif">Certain identified information has been excluded from this
exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.</span></td></tr>
</table>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"><b>MICROBOT
    MEDICAL INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font: 10pt Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font: 10pt Times New Roman, Times, Serif"><i>/s/
    Harel Gadot</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Harel
    Gadot</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer, President and Chairman</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Date:
December 27, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZi22CuujSokWsIqWI22CnEmwzZRL/juQtjS3iMDAM733vCTEROa1NiwynZVlAhV3fao9QYoOM9ozBkW22KYRb4sU4z9r64f2BGQUGAzOfSqmDMFjvxmGdglSxWsRKQjJL5xIOOxF99YxsY2q03ugWtK3hwNSzQa/5NSZU+kmWutdQdUR2hmyImyaj/AaVSAV7uusH8dVBUWQimgwTiZzp1n9rbs5TB6sWu9DlRvS/0QcV0UlG -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TECHNOLOGY
CO-DEVELOPMENT AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
TECHNOLOGY CO-DEVELOPMENT AGREEMENT (the &ldquo;<B>Agreement</B>&rdquo;) is made effective as of the date of last signature (the &ldquo;<B>Effective
Date</B>&rdquo;) by and between <B>Microbot Medical, Inc</B>., a Delaware corporation with a place of business located at 25 Recreation
Park Drive, Suite 108, Hingham, MA 02043, on behalf of itself and its Affiliates (&ldquo;<B>Microbot</B>&rdquo;), and <B>Stryker Corporation,
acting through its Neurovascular Division</B>, a Michigan corporation with a place of business at 47900 Bayside Parkway, Fremont, CA
94538 (&ldquo;<B>Stryker</B>&rdquo;). Stryker and Microbot are referred to herein as either a &ldquo;Party&rdquo; individually, or as
the &ldquo;Parties&rdquo; collectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Microbot has expertise in micro-robotic medical technologies including without limitation, their remote-site-controlled robotic platform,
the &ldquo;LIBERTY&reg; Platform Technology&rdquo;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Stryker has expertise in and is engaged in the development and commercialization of certain medical device products;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Microbot has developed and owns the micro-robotic medical LIBERTY<B>&reg;</B> System (as defined below) (the &ldquo;<B>LIBERTY&reg; System&rdquo;</B>);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
Stryker owns or controls certain intellectual property relating to its medical device products including but not limited to its [***],
and other neurovascular access technology (the &ldquo;<B>Devices Technology</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Parties now desire to enter into a collaborative development program to explore the use of the LIBERTY System in potential new products
and in combination with the Device Technology as further outlined in Exhibit B which is hereby attached to this Agreement (&ldquo;<B>Project</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW
THEREFORE, in consideration of the mutual agreements and understandings set forth herein, the Parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Definitions</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Affiliate&rdquo;
    means, as to any Person, any other Person which directly or indirectly controls, is controlled by, or is under common control with
    such Person. For purposes of the preceding definition, &ldquo;control&rdquo; means beneficial ownership of 50% or more of the outstanding
    voting securities of a Person or the ability to elect a majority of the board of directors or other managing authority of such Person
    or otherwise to control the direction of the management or policies of such Person (whether by contract or otherwise).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Microbot
    Indemnitees&rdquo; has the meaning set forth in Section 8.2.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Microbot
    IP&rdquo; means all Intellectual Property owned or controlled by Microbot.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Background
    IP&rdquo; means all Intellectual Property (a) made, invented, developed, conceived, authored, first reduced to practice, licensed,
    acquired, owned or controlled by a Party prior to the effective date of the first Development Plan under this Agreement or outside
    any Development Plan of this Agreement (b) made, invented, developed, conceived, authored or first reduced to practice under this
    Agreement solely by a Party independently, without using nor relying on the other Party&rsquo;s Confidential Information or (c) licensed,
    acquired, owned or controlled by a Party during the term of this Agreement not under the Development Plan; but excluding any Jointly
    Developed IP. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Challenges&rdquo;
    has the meaning set forth in Section 4.3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.6.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Confidential
    Information&rdquo; means, subject to the exceptions set forth in Section 6.2, all information regarding a Party&rsquo;s technology,
    products or business that is disclosed in such a manner or is of such a character as would put a reasonable person on notice as to
    the confidential and proprietary nature of such information, that such Party discloses or makes available to the other Party under
    this Agreement, or discloses or makes available to the other Party under the Confidentiality Agreement, in each case, whether in
    oral, written, graphic, electronic or other form. The terms and conditions of this Agreement shall be considered Confidential Information
    of both Parties.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Development
    Activities&rdquo; means any and all development, research, inspection, testing or other activities performed, or to be performed,
    by a Party as part of the Project as described in Exhibit B, with respect to the Products described therein, pursuant to this Agreement,
    as more fully set forth and detailed in a Development Plan; for the sake of clarity, Development Activities shall not include any
    activities to commercialize a Product.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.8.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Development
    Plan&rdquo; has the meaning set forth in Section 2.1.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.9.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Field&rdquo;
    means any interventional robotic assisted neurovascular procedures.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Information&rdquo;
    means any and all ideas, concepts, data, know-how, discoveries, improvements, methods, techniques, technologies, systems, specifications,
    analyses, products, practices, processes, procedures, protocols, research, tests, trials, assays, controls, prototypes, formulas,
    descriptions, formulations, submissions, communications, skills, experience, knowledge, plans, objectives, algorithms, reports, results,
    conclusions and other information and materials, irrespective of whether or not copyrightable or patentable and in any form or medium
    (tangible, intangible, oral, written, electronic, observational or other) in which such Information may be communicated or subsist.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Intellectual
    Property&rdquo; means (a) inventions (whether or not patentable) and improvements thereto, patents and patent applications and disclosures
    relating thereto (and any patents that issue as a result of those patent applications), and any renewals, reissues, reexaminations,
    utility models, extensions, continuations, continuations-in-part, divisions, certificate of inventions, and substitutions relating
    to any of the patents and patent applications, as well as all related foreign patent and patent applications that are counterparts
    to such patents and patent applications and any other governmental grant for the protection of inventions or industrial designs,
    (b) trademarks, service marks, trade dress, Internet domain names, logos, brand names, trade names and corporate names, whether registered
    or unregistered, and the goodwill associated therewith, together with any registrations and applications for registration thereof,
    (c) copyrights and rights under copyrights, whether registered or unregistered, including moral rights, and any registrations and
    applications for registration thereof, (d) mask works and registrations and applications for registration thereof; (e) computer software,
    including any source code, machine code, or object code, (f) trade secrets and Information, including, for example, know-how, concepts,
    methods, processes, designs, schematics, drawings, formulae, technical data, specifications, research and development information,
    technology, and business plans, and (g) copies and tangible embodiments of the foregoing.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.12.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;LIBERTY
    Platform Technology&rdquo; means: [***].</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;LIBERTY
    System<B>&rdquo; </B>means a robotic system based upon the LIBERTY Platform Technology [***], as further defined detailed in <U>Exhibit
    A</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.14.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Jointly
    Developed IP&rdquo; means all Intellectual Property first made, invented, conceived, authored, developed, created or reduced to practice
    after the Effective Date as a result of the joint efforts (i.e., at least one inventor from each Party) of the Parties or their Affiliates,
    pursuant to any Development Plan under this Agreement. Inventorship shall be determined by United States patent law. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.15.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;Person&rdquo;
    means an individual, corporation, partnership, joint venture, limited liability entity, governmental authority, unincorporated organization,
    trust, association or other legal person or entity.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.16.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Product(s)&rdquo;
    means the Product for use in the Field that incorporates, or is based on, the combination or the joint use of the LIBERTY System
    and the Devices Technology that result from the Project as set out in the Project (Exhibit B) and any Development Plan associated
    therewith. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.17.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Stryker
    Indemnitees&rdquo; has the meaning set forth in Section 8.1.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Territory&rdquo;
    means every country in the world. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Third
    Party&rdquo; means any entity other than Stryker or Microbot or an Affiliate of Stryker or Microbot.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Joint Development Activities</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Development
    Plans</U>. The Development Activities with respect to the Project identified in Exhibit B, to be performed by each Party shall be
    specified in writing in one or more Development Plans to be derived from Exhibit B (each, a &ldquo;<B>Development Plan</B>&rdquo;)
    to be mutually agreed to and signed by both Parties, which shall include the timeline and schedule for the Development Activities,
    any deliverables and any other relevant terms and conditions. Each Development Plan shall be incorporated herein by this reference
    and shall be subject to all of the terms and conditions of this Agreement. To the extent any terms or conditions of a Development
    Plan conflict with the terms and conditions of this Agreement, the terms and conditions of the Development Plan shall control. Any
    changes to a Development Plan shall be in writing, executed by each Party, and attached to the original Development Plan. The Parties
    shall use commercially reasonable efforts to work together to develop the Products in accordance with the terms and conditions of
    this Agreement and any Development Plan.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Records;
    Results</U>. Each Party shall keep accurate and complete records that generally reflect all work done and results achieved in the
    performance of the Development Activities, including all information used or developed in connection therewith. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Costs
    and Expenses</U>. Except as otherwise provided in this Agreement or a Development Plan, each Party will bear its own costs and expenses
    in connection with the performance of this Agreement and its assigned Development Activities, including, but not limited to, labor,
    management, engineering, travel, time, and equipment necessary to carry out its obligations set forth herein.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
COVENANTS Related TO iP</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Microbot
    Covenants</U>. Microbot hereby covenants that at no time shall it, directly or indirectly, initiate, induce, assist or participate
    in any action or proceeding against Stryker, its affiliates, successors and assigns, based upon an assertion that Stryker&rsquo;s
    performance of its Development Activities under a Development Plan infringes any of Microbot&rsquo;s Background IP. For avoidance
    of doubt, the covenant granted hereunder shall not include the right of Stryker to commercialize any Products or to use any of Microbot&rsquo;s
    Background IP for any purpose other than the performance of Stryker&rsquo;s Development Activities hereunder without further written
    agreement between the Parties.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stryker
    Covenants</U>. Stryker hereby covenants that at no time shall it, directly or indirectly, initiate, induce, assist or participate
    in any action or proceeding against Microbot, its affiliates, successors and assigns, based upon an assertion that Microbot&rsquo;s
    performance of its Development Activities under a Development Plan under this Agreement infringes any of Stryker&rsquo;s Background
    IP. For avoidance of doubt, the covenant granted hereunder shall not include the right of Microbot to commercialize any Products
    or to use any of Stryker&rsquo;s Background IP for any purpose other than the performance of Microbot&rsquo;s Development Activities
    hereunder without further written agreement between the Parties.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Ownership and Intellectual Property Rights</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Background
    IP</U>. The Parties acknowledge and agree that (a) each Party shall retain its right, title and interest, if any, in its Background
    IP and (b) neither this Agreement, nor either Party&rsquo;s performance hereunder, shall alter the ownership of, or either Party&rsquo;s
    rights in or to, its Background IP. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reservation
    of Rights</U>. Except as expressly provided in this Agreement, under no circumstances shall a Party acquire or obtain any ownership
    interest or other licenses, right, title or interest in or to any Background IP or Confidential Information of the other Party, whether
    by implication, estoppel or otherwise. Any rights not expressly granted herein are reserved.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jointly
    Developed IP</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Ownership</U>.
    Jointly Developed IP shall be owned by one Party and licensed back to the other Party as further detailed below. Ownership will be
    based on the nature of the Jointly Developed IP as it relates to each Parties&rsquo; respective business, i.e. in the case of Microbot
    &ndash; Microbot will own the Jointly Developed IP in the field of the LIBERTY Platform Technology, and in the case of Stryker &ndash;
    Stryker will own the Jointly Developed IP in the field of the Devices Technology (each such business shall be referred to as the
    applicable party&rsquo;s &ldquo;<B>Business</B>&rdquo;). </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>4.3.2.</I></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    Party agrees to execute any documents that the other Party may reasonably request to confirm the other Party&rsquo;s title to and
    ownership of the Jointly Developed IP.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>License
    of Jointly Developed IP</U>. The Party assigned the Jointly Developed IP grants to the other Party a worldwide, irrevocable, perpetual,
    royalty-free, paid-up, nonexclusive, sub-licensable license to the Jointly Developed IP. For the avoidance of doubt, this license
    does not extend to the Background IP of the assigning Party, which is not being licensed hereunder. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prosecution
    and Maintenance of Equal Joint IP</U>. If the Jointly Developed IP relates equally and undividedly both to the LIBERY Platform Technology
    and to the Devices Technology, such that such Jointly Developed IP cannot be identified as pertaining exclusively to either Party&rsquo;s
    Business (&ldquo; <B>Equal Joint IP</B>&rdquo;), such Jointly Developed IP shall be jointly and equally owned by bother Parties.
    The Parties shall mutually agree upon (a) a patent filing strategy for the Equal Joint IP and (b) which Party shall prosecute any
    patent applications covering Equal Joint IP. Neither Party shall file any patent application covering Equal Joint IP without the
    prior written consent of the other Party. The prosecuting Party for the Equal Joint IP shall consult with the non-prosecuting Party
    on all matters concerning the preparation, filing, prosecution and maintenance of all patent applications, amendments and other documents
    relating to any Equal Joint IP, including the selection of patent counsel to handle any matter concerning Equal Joint IP, and shall
    consider all input and information and implement all reasonable requests provided by the non-prosecuting Party. Except as otherwise
    provided in this Section 4.3.3, the Parties shall share equally the costs of searching, preparing, filing and prosecuting patent
    applications (and maintaining resulting patents) for Equal Joint IP. If a Party desires to file a patent application in a given country
    claiming Equal Joint IP and the other Party declines to participate, the declining Party shall not be required to share in such costs
    but shall assign its ownership rights in such Equal Joint IP in such country to the filing Party and the filing Party shall grant
    to the declining Party an irrevocable, perpetual, royalty free, paid-up, non-exclusive license under such Equal Joint IP. If a Party
    desires to abandon or discontinue its participation in or payment for any patent application or issued patent claiming Equal Joint
    IP, such Party shall inform the other Party at least two (2) months prior to any potential abandonment so that the other Party may
    decide whether to have such patent application or patent maintained, and if so, the Party will assign it rights in such patent application
    or patent to the other Party and the other Party shall grant to the Party an irrevocable, perpetual, royalty-free, paid-up, non-exclusive
    license to the patent application or patent.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.5.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Enforcement
    of Jointly Developed IP and Equal Joint IP</U>. Each Party shall promptly notify the other Party of an infringement of any Jointly
    Developed IP and Equal Joint IP of which such Party becomes aware. In the case of Equal Joint IP, the Parties shall consult with
    one another to determine which Party, or whether the Parties together, shall initiate action against an infringer, including legal
    action. The non-initiating Party, if any, shall fully cooperate with and assist the initiating Party in any such action and the initiating
    Party shall reimburse the other Party for reasonable out-of-pocket expenses it incurs in providing the requested assistance. The
    initiating Party(ies) shall be entitled to retain all damages that it is awarded in any such action. If the Parties cannot agree
    whether or which Party shall initiate an infringement action, then either Party may independently pursue such action, provided that
    the Party pursuing such action gives the other Party not less than 30 days of prior written notice of its decision to pursue such
    action and the opportunity to share equally in the costs of pursuing such action. If the Parties share equally the costs of the action,
    then all damages awarded in such action shall be shared equally by the Parties. Otherwise, any recovery from such action shall be
    divided between the Parties in proportion to their contributions to the action.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>4.3.6.</I></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Defense
    of Jointly Developed IP and Equal Joint IP</U>. Each Party shall promptly notify the other Party of any action, threat of action,
    lawsuit, proceeding, litigation or other allegations challenging the validity of any Jointly Developed IP or Equal Joint IP (collectively
    &ldquo;Challenges&rdquo;), regardless of whether the Challenges arise or may arise in a judicial or administrative forum, including
    without limitation any petition for <I>inter partes</I> review. In the case of Equal Joint IP, the Parties shall consult with one
    another to determine which Party, or whether the Parties together, will defend against such Challenges. The non-defending Party,
    if any, shall fully cooperate with and assist the defending Party in any such proceedings. The defending Party shall reimburse the
    non-defending Party for reasonable out-of-pocket expenses it incurs in providing the requested assistance. If a Party or the Parties
    together choose to defend against any Challenges, the Parties shall consult with one another in good faith to determine an arrangement
    for paying the costs of defending against any such Challenges. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.7.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>License
    Out of Equal Joint IP</U>. Each Party shall have the right to use the Equal Joint IP as it deems fit, without the consent of, and
    without accounting to, the other Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Termination</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Term</U>.
    The term of this Agreement shall commence on the Effective Date and continue until the completion of the last Development Plan agreed
    upon, unless the Agreement is terminated earlier by either Party in accordance with this Article 5.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Termination</U>.
    The Parties shall initially attempt to resolve all claims, disputes or controversies arising under, out of or in connection with
    this Agreement by conducting good faith negotiations with their respective management. This Agreement may be terminated as follows:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    either party upon written notice to the other Party if such other Party materially breaches any provision of this Agreement and,
    if such breach is curable, fails to cure such breach within 30 days of delivery of written notice of such breach;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    either Party upon written notice to the other Party if such other Party: (a) becomes insolvent or admits its inability to pay its
    debts generally as they become due; (b) becomes subject, voluntarily or involuntarily, to any proceeding under any domestic or foreign
    bankruptcy or insolvency law, which is not stayed within 60 days after filing; (c) is dissolved or liquidated or takes any corporate
    action for such purpose; (d) makes a general assignment for the benefit of creditors; or (e) has a receiver, trustee, custodian or
    similar agent appointed by order of any court of competent jurisdiction to take charge of or sell any material portion of its property
    or business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    either Party upon written notice reasonably in advance to the other Party if reasonably necessary to facilitate regulatory approval
    of a merger or other acquisition transaction; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    the non-assigning Party, immediately upon written notice, in the event the other Party undergoes a merger, change of control, acquisition
    of its assets pertaining to this Agreement. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.5.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    either Party for any reason or no reason upon 60 days written notice to the other Party.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Effect
    of Termination</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    notice of termination of this Agreement for any reason, the Parties shall continue to perform in accordance with the Agreement until
    the termination date. On the termination date, ownership of any work-in-process shall be determined in good faith by the Parties
    in accordance with Article 4, and any and all information, including, without limitation, designs, methods, know-how, research, documentation
    and data related to such work-in-process and which may be developed utilizing such work-in-process as of the termination date shall
    be provided to each Party. Any costs associated with reproduction of such information shall be shared equally by the Parties regardless
    of which Party is in possession of such information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination
    of this Agreement shall not relieve the Parties of any obligations accruing prior to the effective date of termination. Any termination
    of this Agreement shall not preclude either Party from pursuing all rights and remedies it may have hereunder at law or in equity
    with respect to any breach of this Agreement nor prejudice either Party&rsquo;s right to obtain performance of any obligation.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Survival</U>.
    The rights and obligations of the Parties set forth in Articles 3, 4, 7, 8, 9 and 10 and Sections 6.3 and 6.4, and any right, obligation
    or required performance of the Parties in this Agreement which, by its express terms survives termination of this Agreement, shall
    survive any such termination.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Confidentiality</U>.
    Each Party agrees that during the term of this Agreement and for a period of five (5) years thereafter, such Party will protect and
    hold the other Party&rsquo;s Confidential Information in trust and confidence, that it will not use such Confidential Information
    in any manner or for any purpose not expressly set forth in this Agreement, and will not disclose any such Confidential Information
    to any party other than to its personnel who has a &ldquo;need to know&rdquo; such Confidential Information for the purpose of performing
    this Agreement. without first obtaining the other Party&rsquo;s consent on a case-by-case basis. However, with respect to Confidential
    Information that constitutes a trade secret under applicable law, such rights and obligations will survive such expiration until,
    if ever, such Confidential Information loses its trade secret protection other than due to an act or omission of Receiving Party
    or its Representatives. The Parties hereto understand and agree that this Article 7 is reasonable and necessary to protect each Party&rsquo;s
    business interests and in addition to any other rights or remedies it may have at law or in equity, each Party shall be entitled
    to seek injunctive relief with respect to any breach or threatened breach of this Article 7 without the necessity of the proof of
    actual damages or the posting of a bond or other security.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.</FONT></TD>
    <TD COLSPAN="2" STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Knowledge
    of the relationship between Stryker and Microbot is considered Confidential Information between the Parties, and neither party may
    disclose the terms of this Agreement or any Development Plan without the prior written consent of the Other Party, such consent shall
    not be unreasonably withheld. Notwithstanding the above, disclosure of such existence and/or terms of this Agreement (including a
    reproduction of and/or summary of the terms of this Agreement) may be disclosed by a Party hereunder (a) to a Third Party, without
    the consent of the other Party, in customary due diligence processes with respect to such Party and/or its respective business and
    (b) in accordance with applicable United States securities laws and the rules and regulation thereunder, and the rules and regulations
    of any stock exchange a Party&rsquo;s securities are then listed, traded or quoted, all as reasonably determined by the disclosing
    Party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exceptions</U>.
    Confidential Information of a disclosing Party shall not include information which the receiving Party can demonstrate by competent
    evidence: (a) is now or hereafter becomes part of the public domain through no breach of this Agreement by the receiving Party, (b)
    is known by the receiving Party at the time of receiving such information from the disclosing Party, as evidenced by its written
    records, (c) is rightfully received by the receiving Party from a Third Party without a duty of confidentiality or other restriction
    on disclosure, or (d) is independently developed by the receiving Party without the use of or reference to Confidential Information
    of the disclosing Party, as evidenced by the receiving Party&rsquo;s written records.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorized
    Disclosure</U>. Each Party may disclose Confidential Information belonging to the other Party to the extent such disclosure is reasonably
    necessary in the following instances: (a) complying with applicable court orders or applicable laws, rules or regulations; and (b)
    disclosure to a Party&rsquo;s Affiliates, provided that Confidential Information so disclosed shall remain subject to this Article
    7. In the event a Party is required to make a disclosure of the other Party&rsquo;s Confidential Information pursuant to the preceding
    clause (a), it will, (i) to the extent permitted by applicable law, provide prompt written notice to the other Party so that such
    other Party may seek a protective order or other appropriate remedy, and (ii) disclose only the portion of Confidential Information
    that it is legally required to furnish. If a protective order or other remedy is not obtained, or the disclosing Party waives compliance
    under this Article 7, the receiving Party shall use reasonable efforts to obtain assurance that confidential treatment will be afforded
    the Confidential Information.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Pre-existing
    Projects</U>. Each of the Parties, as a disclosing Party, understands that the other Party, as a receiving Party, may currently or
    in the future be developing information internally, or receiving information from others that may be similar to the disclosing Party&rsquo;s
    Confidential Information. Nothing in this Agreement shall limit a receiving Party&rsquo;s existing research and/or development, plans
    or programs in existence when the Confidential Information is disclosed to the extent that the receiving Party does not use the Confidential
    Information belonging to the disclosing Party as part of its existing research and/or development plans or programs. Nothing in this
    Agreement shall be construed as a representation or inference that the receiving Party shall not develop products or services or
    have products or services developed for the receiving Party that, without violation of this Agreement, compete with the products
    or systems contemplated by the disclosing Party&rsquo;s Confidential Information. Nothing in this Agreement shall be construed or
    interpreted to prevent the receiving Party from filing a patent application on the receiving Party&rsquo;s own inventions that were
    conceived independently of the disclosing Party&rsquo;s Confidential Information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Representations, Warranties and COVENANTS; disclaimer</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mutual
    Representations and Warranties</U>. Each Party represents and warrants that (a) such Party is duly organized, validly existing and
    in good standing under the laws of the place of its establishment or incorporation, (b) such Party has taken all action necessary
    to authorize it to enter into this Agreement and perform its obligations under this Agreement, (c) this Agreement will constitute
    the legal, valid and binding obligation of such Party, (d) neither the execution of this Agreement nor the performance of such Party&rsquo;s
    obligations hereunder will conflict with, result in a breach of, or constitute a default under any provision of the organizational
    documents of such Party, or of any law, rule, regulation, authorization or approval of any government entity, or of any agreement
    to which it is a party or by which it is bound, and (e) such Party is financially solvent and has sufficient working capital to perform
    all of its duties and obligations under this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants</U>.
    Each Party represents, warrants and agrees that: (a) it will perform all of its obligations under this Agreement in a professional
    and workmanlike manner according to industry standards; and (b) it will comply in all material respects with all applicable laws
    governing this Agreement and its performance hereunder.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disclaimer</U>.
    Except as expressly set forth herein, <FONT STYLE="text-transform: uppercase">each Party expressly disclaims any and all warranties
    of any kind, express or implied, including without limitation, any warranty of design, merchantability, fitness for a particular
    purpose, non-infringement of the intellectual property rights of third parties, or arising from a course of dealing, usage or trade
    practices, in respect of the Intellectual Property furnished or Development Activities provided by such Party pursuant to this Agreement.</FONT></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limitation
    of Liability</U>. <FONT STYLE="text-transform: uppercase">Except for liability for breach of Article 6 and Section 4.1, neither Party
    shall be liable to the other Party for any DIRECT, incidental, indirect, special, punitive or consequential damages, or for lost
    profits, savings or revenues of any kind, or for loss ARISING OUT OF THIS AGREEMENT ;</FONT> provided, however, that this Section
    <B><I>&lrm;</I></B>7.4 shall not be construed to limit either Party&rsquo;s indemnification rights or obligations under Article 8.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Microbot
    Indemnification Obligations</U>. Microbot shall defend Stryker and its officers, directors, employees, consultants and agents (&ldquo;Stryker
    Indemnitees&rdquo;) from and against any and all Third Parties&rsquo; claims, demands, action or proceeding by any Third Party (&ldquo;Claims&rdquo;)
    which arise out of (a) a material breach of the confidentiality obligations hereunder; (b) the gross negligent or intentional misconduct
    of Microbot, or (c) the violation of any applicable law or regulation by Microbot and shall indemnify and hold harmless Stryker Indemnitees
    from and against losses, damages, liabilities, claims, costs, charges, judgments and expenses (including reasonable attorneys&rsquo;
    fees) awarded in such Claims by a competent jurisdiction or in a settlement to which Microbot is a party&rdquo;) .</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stryker
    Indemnification Obligations</U>. Stryker shall defend Microbot and its officers, directors, employees, consultants and agents (&ldquo;Microbot
    Indemnitees&rdquo;) from and against any and all Claims which arise out of (a) a material breach of the confidentiality obligations
    hereunder; (b) the gross negligent or intentional misconduct of Stryker, or (c) the violation of any applicable law or regulation
    by Stryker and shall indemnify and hold harmless Microbot Indemnitees from and against losses, damages, liabilities, claims, costs,
    charges, judgments, and expenses (including reasonable attorneys&rsquo; fees) awarded in such Claims by a competent jurisdiction
    or in a settlement to which Stryker is a party.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; text-transform: uppercase"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Force
    Majeure</U>. Neither Party shall be liable, or be deemed to be in default, to the other Party hereunder by reason or on account of
    any delay or omission caused by epidemic, fire, power outages, action of the elements, strikes, lockouts, labor disputes, governmental
    law, regulations, ordinances, order of a court of competent jurisdiction, executive decree or order, act of God or public enemy,
    terrorism, war, riot, civil commotion, earthquake, flood, accident, explosion, casualty, embargo or any other cause beyond the control
    of such Party, or any act, delay or omission not due to the negligence or default of such Party. The time of performance for each
    Party&rsquo;s obligations under this Agreement shall be extended by such period of enforced delay; provided, however, that in the
    event such period of extended delay exceeds 60 days with respect to a Party, the other Party may terminate this Agreement upon notice
    to such Party.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices</U>.
    All notices or demands in connection with this Agreement given to or made upon either Party shall be in writing and sent to the Party
    at the following address, as may be modified from time to time by written notice:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Microbot
    Medical, Inc</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stryker
    Corporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25
    Recreation Park Drive, Suite 108</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47900
    Bayside Parkway</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hingham,
    MA 02043</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fremont,
    CA 94538</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
    (781) 875-3605</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ph:
    (510) 413-2500</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
    (781) 556 -5347</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
    (844) 325-6664</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Harel Gadot</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
    Legal Department</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:<U>harel@microbotmedical.com
    </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    <U>NVLegal@stryker.com</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Assignment</U>.
    Neither this Agreement nor any of the rights or obligations created herein may be assigned by either Party, in whole or in part (including
    any assignment by operation of law), without the prior written consent of the other Party, except that each Party shall be free to
    assign this Agreement without the prior consent of the other Party (a) to an Affiliate, or (b) in connection with any merger, sale
    of a Party or sale of all or substantially all of the assets or stock of a Party that relate to this Agreement, (but subject to the
    right of the other Party to terminate this Agreement in the circumstances described in Section <B><I>&lrm;</I></B>5.2.4). This Agreement
    shall bind and inure to the benefit of the successors and permitted assigns of the Parties. Any assignment of this Agreement in contravention
    of this Section 9.3 shall be null and void.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Entire
    Agreement</U>. This Agreement sets forth the entire understanding of the Parties hereto with respect to the subject matter hereof,
    and may not be modified, amended, supplemented or waived, except by a writing signed by both Parties. This Agreement supersedes and
    replaces in its entirety any prior or contemporaneous agreement, whether written or oral, between the Parties with respect to the
    subject matter hereof.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Waiver</U>. A waiver, express or implied, by either Party of any right of such Party hereunder or of any breach hereof by the other
    Party will not constitute or be deemed to be a waiver of any other right hereunder or of any breach hereof by such other Party, whether
    of a similar or dissimilar nature thereto.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Independent
    Contractors</U>. The relationship between Stryker and Microbot created by this Agreement is solely that of independent contractors.
    This Agreement does not create any agency, distributorship, employer-employee, partnership, joint venture or similar business relationship
    between the Parties. Neither Party is a legal representative of the other Party, and neither Party can assume or create any obligation,
    representation, warranty or guarantee, express or implied, on behalf of the other Party for any purpose whatsoever. Each Party shall
    use its own discretion and shall have complete and authoritative control over its employees and the details of performing its obligations
    under this Agreement. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing
    Law</U>. The Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York without
    regard to its conflicts of laws principles. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Equitable
    Relief</U>. Each Party acknowledges that a breach by the other party of this Agreement may cause the non-breaching Party irreparable
    harm, for which an award of damages would not be adequate compensation and, in the event of such a breach or threatened breach, the
    non-breaching Party shall be entitled to seek equitable relief, including in the form of a restraining order, orders for preliminary
    or permanent injunction, specific performance and any other relief that may be available from any court. These remedies shall not
    be deemed to be exclusive but shall be in addition to all other remedies available under this Agreement at law or in equity, subject
    to any express exclusions or limitations in this Agreement to the contrary.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.9.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Third Party Beneficiaries</U>. This Agreement is for the sole benefit of the Parties hereto and their respective successors and permitted
    assigns and nothing herein, express or implied, is intended to or shall confer upon any other Persons any legal or equitable right,
    benefit or remedy of any nature whatsoever, under or by reason of this Agreement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.10.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability</U>.
    If any provision of this Agreement shall be declared invalid or illegal for any reason whatsoever, then notwithstanding such invalidity
    or illegality, the remaining terms and provisions of this Agreement shall remain in full force and effect in the same manner as if
    the invalid or illegal provision had not been contained herein; provided that the illegal, invalid or unenforceable provisions are
    not material to the overall purposes or operation of the Agreement, and such invalid, unenforceable or illegal provision shall be
    valid, enforceable and legal to the maximum extent permitted by law.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.11.</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Counterparts</U>.
    This Agreement may be executed in any number of counterparts (including those delivered by facsimile or other electronic means),
    each of which shall be considered an original and all of which taken together shall constitute one and the same instrument.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
Page Follows]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS, WHEREOF, the Parties hereto have caused this Agreement to be executed by their duly authorized representatives as of the Effective
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STRYKER CORPORATION acting through its
    NEUROVASCULAR DIVISION</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT MEDICAL, INC</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Roskopf</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Harel Gadot</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Roskopf</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
    President, Business Development and Strategic Planning </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>December
    22, 2021</U></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    14, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
A &ndash; The LIBERTY System</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
B &ndash; Product Development Plan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>LIBERTY
SYSTEM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>[***]<BR STYLE="clear: both">
</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
                                            Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PRODUCT
DEVELOPMENT PLAN</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following Development Plan is an Exhibit to the Technology Co-Development Agreement (<B>&ldquo;Agreement&rdquo;</B>) entered into by
and between <B>Stryker Corporation</B>, <B>acting through its Neurovascular Division</B> (<B>&ldquo;Stryker&rdquo;</B>), and <B>Microbot
Medical, Inc (&ldquo;Microbot&rdquo;)</B>. This Development Plan will be governed by the Agreement and as set forth below. Capitalized
terms used in this Development Plan without definition will have the respective meanings given to them in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STRYKER
DIVISION</B>: <B><U>Neurovascular</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROJECT
DESCRIPTION OR NAME</B>: <B><U>Robotic Neurovascular Access Project involving the LIBERTY System and the Devices Technology (</U></B><U>as
defined in the Agreement)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Scope
    of Development Plan</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stryker
desires to partner with Microbot to collaborate in the development of NV applications that integrate the LIBERTY System of Microbot and
the Devices Technology of Stryker (as such terms are defined in the Agreement) (the &ldquo;<B>Project</B>&rdquo;). Products created from
the Project, if any, shall be for use in the Field in the Territory.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stryker
will dedicate non-cash resources to the Project that include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]
    </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
will dedicate non-cash resources to the Project that include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Project will be completed in phases as outlined in Table 1 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
Identified Information Has Been Excluded From The Exhibit Because It Is Both (I)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Not
Material And (Ii) Would Be Competitively Harmful If Publicly Disclosed</I></B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
1. Project Phases</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Design
    and Development Phase</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
    of Activities</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; width: 24%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Estimated
    Timing</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Term</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of this Development Plan shall be from the Effective Date until the completion of the Project or as otherwise terminated in accordance
with the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Regulatory</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
Stryker and Microbot shall provide documentation, and other reasonable support as requested to assist with regulatory filings as may
be needed in Phase II and/or Phase III. However, Microbot will not provide any documentation to Stryker without the written request from
Stryker and will limit such documentation to the minimal amount reasonable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms set forth in this Development Plan may be amended as mutually agreed and signed by both Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Parties hereto have caused this Development Plan to be executed by their duly authorized corporate officers
or representative as of the date signed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STRYKER CORPORATION acting through its
    NEUROVASCULAR DIVISION</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MICROBOT MEDICAL, INC</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Roskopf</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Harel Gadot</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bill
    Roskopf</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Harel
    Gadot</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vice
    President, Business Development &amp; Strategic Planning</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    CEO &amp; Chairman </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>December
    22, 2021</U></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    14, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Microbot
Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY<SUP>&reg;</SUP> Robotic System for Neurovascular
Applications</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HINGHAM,
Mass., December 27, 2021</B> &ndash; Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a strategic collaboration
agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker&rsquo;s Neurovascular
division to integrate its neurovascular instruments with Microbot&rsquo;s LIBERTY Robotic System to develop the world&rsquo;s first dedicated
robotic procedural kits for use in certain neurovascular procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;We
have already ensured that the LIBERTY Robotic System has a strong and sustainable competitive advantage, and the collaboration with Stryker
will allow us to further expand in the neurovascular space,&rdquo; commented Harel Gadot, Chairman, CEO and President of Microbot Medical.
&ldquo;I believe the similarities in our innovation culture, as well as our complementary core capabilities, will allow us to establish
a truly differentiated solution that will benefit all stakeholders and accelerate our goal of changing the way robotic surgery is viewed
and adopted.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company will continue to develop the LIBERTY Robotic System independently for use in peripheral and coronary procedures. The animal feasibility
studies to date support the company&rsquo;s assertion that it will potentially allow physicians to safely and efficiently conduct remote
catheter-based vascular procedures, and reduce the risk for radiation exposure, physical strain on the user and Hospital Acquired Infections
(HAIs), without the need for cumbersome and expensive capital equipment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Microbot Medical</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies,
focused primarily on both natural and artificial lumens within the human body. Microbot&rsquo;s current proprietary technological platforms
provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Microbot
Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for
patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available
at <U>http://www.microbotmedical.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Safe
Harbor</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>Statements
pertaining to the collaboration between the company and Stryker, the advancement of the LIBERTY Robotic System covered by the collaboration
agreement and the potential benefits of such collaboration and statements pertaining to future financial and/or operating results, future
growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along
with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements
that are not historical fact (including, but not limited to statements that contain words such as &ldquo;will,&rdquo; &ldquo;believes,&rdquo;
&ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects&rdquo; and &ldquo;estimates&rdquo;) should also be considered to be forward-looking
statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent
in the development and/or commercialization of potential products, including LIBERTY and SCS, the outcome of its studies to evaluate
LIBERTY, SCS and other existing and future technologies, uncertainty in the results of pre-clinical and clinical trials or regulatory
pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance
of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading &ldquo;Risk Factors&rdquo;
in Microbot Medical&rsquo;s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC&rsquo;s
web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required
by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>Michael
Polyviou</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EVC
Group</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">mpolyviou@evcgroup.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">732-933-2754</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !7 .$# 2(  A$! Q$!_\0
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KBB@"YH7A'1/#,ER^D:39Z8]RVZ8VD"Q^81G!; YZG\ZV*** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbot-20211222_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbot-20211222_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://microbotmedical.com/role/Cover" xlink:href="mbot-20211222.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://microbotmedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>mbot-20211222.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.11a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWauHmbP9z5Z8yekhvWB9bZm6byku2Sev/yu6LIOmcdAA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:MBOT="http://microbotmedical.com/20211222" elementFormDefault="qualified" targetNamespace="http://microbotmedical.com/20211222">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://microbotmedical.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="mbot-20211222_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="mbot-20211222_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.4</span><table class="report" border="0" cellspacing="2" id="idm140708767038712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 22,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-19871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MICROBOT
MEDICAL INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3078125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">25
Recreation Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Unit 108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Hingham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">875-3605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBOT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbot-20211222.xsd" xlink:type="simple"/>
    <context id="From2021-12-22to2021-12-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883975</identifier>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-12-22to2021-12-22">0000883975</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-12-22to2021-12-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-12-22to2021-12-22">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-12-22to2021-12-22">2021-12-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-12-22to2021-12-22">MICROBOT MEDICAL INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-12-22to2021-12-22">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-12-22to2021-12-22">000-19871</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-12-22to2021-12-22">94-3078125</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-12-22to2021-12-22">25 Recreation Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-12-22to2021-12-22">Unit 108</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-12-22to2021-12-22">Hingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-12-22to2021-12-22">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-12-22to2021-12-22">02043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-12-22to2021-12-22">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-12-22to2021-12-22">875-3605</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-12-22to2021-12-22">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-12-22to2021-12-22">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-12-22to2021-12-22">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-12-22to2021-12-22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-12-22to2021-12-22">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-12-22to2021-12-22">MBOT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-12-22to2021-12-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-12-22to2021-12-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M]@+X?JV4>1_877#^(T;_'U!+ P04    " "E.)M3GZ ;\+$"  #B#   #0
M 'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$
M>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-
M^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZF
MTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,7
M8&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/
MQA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<
M45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,
M%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>
M]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M
M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJR
MY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VW
ML,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VL
MT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/
MAG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+
MV.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0
MIA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " "E.)M3EXJ[
M',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6
M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV
M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O
M@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=
MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (
M *4XFU.JQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5
M*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!
MZ)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y
M&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>
MB/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\
M@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!
M=09#K+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV
M4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " "E.)M3)!Z;
MHJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P
M#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=N
MH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFB
MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6
M<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ I3B;
M4V60>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O
M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1
ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K
MU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8
M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"
MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R
M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>
M?P%02P$"% ,4    " "E.)M3!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *4XFU,HH:6P[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( *4XFU.97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ I3B;4\W:)6Y'!   T!   !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( *4XFU.?H!OPL0(  .(,   -              "  8L,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ I3B;4Y>*NQS     $P(   L
M ( !9P\  %]R96QS+RYR96QS4$L! A0#%     @ I3B;4ZK$(A8S 0  (@(
M  \              ( !4!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M *4XFU,D'INBK0   /@!   :              "  ; 1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *4XFU-ED'F2&0$  ,\#   3
M              "  942  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  -\3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://microbotmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex99-1.htm</File>
    <File>mbot-20211222.xsd</File>
    <File>mbot-20211222_lab.xml</File>
    <File>mbot-20211222_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mbot-20211222_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbot-20211222_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mbot-20211222.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "MBOT",
   "nsuri": "http://microbotmedical.com/20211222",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2021-12-22to2021-12-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://microbotmedical.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2021-12-22to2021-12-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://microbotmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-21-032474-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-032474-xbrl.zip
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M%)BAY1"^2%V0"5)NW_/ .?$;XV6Y'NXB;"\+Z6ER5&;F3<;Q]EZL 915NY0
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MC5M:SMPE;P://=O=[M*?T8:_JZ4_O_TG4$L#!!0 " @( *8XFU,
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MJ)U>KJXT:N=GC<NEIRJ@?.Z[PJ>VM[KB.?!8Q_ 9R1>(XY)\:<U8?PMC<-J
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M<K:BMJ@JCK%@5=]=U7W*MC]]O<DGH0MP?Q'#GQ[KN4X?N7Y:&=P#3U0-)AV
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MQ+0EE1=<>\,\ZBE@J9A$3'1/S_DX58=2A3]PMK'NMBPYLR3^EJZJ>'5HQ"X
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M;,LZBFC1NH8$M&N"TA(&!0OD#@1&!6ANBA#OT/R38#X,F9K2#S MJW9<*EF
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M,"TQ+FAT;5!+ 0(4 !0   @( *4XFU,E6_A+4PH  (4K   *
M     +1'  !E>#DY+3$N:'1M4$L! A0 %  (" @ ICB;4YH%K&?;%@  +*0
M  L                 +U(  &9O<FTX+6LN:'1M4$L! A0 %   " @ I3B;
M4U?2/ZP^ P  "@P  !$                 0VD  &UB;W0M,C R,3$R,C(N
M>'-D4$L! A0 %   " @ I3B;4_FN/4__"@  ;(<  !4
ML&P  &UB;W0M,C R,3$R,C)?;&%B+GAM;%!+ 0(4 !0   @( *4XFU,GQ6*;
M6 <  ,]8   5                 .)W  !M8F]T+3(P,C$Q,C(R7W!R92YX
8;6Q02P4&      8 !@!N 0  ;7\

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
